ID: ALA5219488

Max Phase: Preclinical

Molecular Formula: C10H13N3O

Molecular Weight: 191.23

Representations

Canonical SMILES:  CC[C@H]1Cc2cc(C(N)=O)cnc2N1

Standard InChI:  InChI=1S/C10H13N3O/c1-2-8-4-6-3-7(9(11)14)5-12-10(6)13-8/h3,5,8H,2,4H2,1H3,(H2,11,14)(H,12,13)/t8-/m0/s1

Standard InChI Key:  NXQWYWSEMMNBMC-QMMMGPOBSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type:

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 191.23

Molecular Weight (Monoisotopic): 191.1059

AlogP: 0.93

#Rotatable Bonds: 2

Polar Surface Area: 68.01

Molecular Species: NEUTRAL

HBA: 3

HBD: 2

#RO5 Violations: 0

HBA (Lipinski): 4

HBD (Lipinski): 3

#RO5 Violations (Lipinski): 0

CX Acidic pKa:

CX Basic pKa: 5.39

CX LogP: 0.65

CX LogD: 0.65

Aromatic Rings: 1

Heavy Atoms: 14

QED Weighted: 0.73

Np Likeness Score: 0.08

References

1. Barrows RD, Jeffries DE, Vishe M, Tukachinsky H, Zheng SL, Li F, Ma Z, Li X, Jin S, Song H, Zhang R, Zhang S, Ni J, Luan H, Wen L, Rongshan Y, Ying C, Shair MD..  (2022)  Potent Uncompetitive Inhibitors of Nicotinamide N-Methyltransferase (NNMT) as In Vivo Chemical Probes.,  65  (21.0): [PMID:36288465] [10.1021/acs.jmedchem.2c01166]

Source

Source(1):

• Scientific Literature